Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.04 USD | +1.13% | -8.98% | -30.06% |
Mar. 01 | Citigroup Cuts Schrodinger Price Target to $39 From $47, Maintains Buy Rating | MT |
Mar. 01 | Goldman Sachs Cuts Schrodinger's Price Target to $26 From $29, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.06% | 1.81B | |
+9.52% | 3,060B | |
+2.46% | 80.48B | |
+7.83% | 80.07B | |
-13.33% | 53.61B | |
-17.99% | 50.6B | |
+24.11% | 47.15B | |
+11.35% | 39.16B | |
+37.36% | 31.53B | |
-11.05% | 24.42B |
- Stock Market
- Equities
- SDGR Stock
- News Schrödinger, Inc.
- Schrödinger : Schrodinger Working With Centessa Pharmaceuticals Subsidiary to Discover Novel Therapeutics for Various Sleep Disorders